Brazil's National Health Surveillance Agency (ANVISA) on Monday said that it has approved trials with a third dose of the Oxford-AstraZeneca vaccine against COVID-19. A third dose of the vaccine would be administered to 10,000 volunteers between 11 and 13 months after the second shot, it added. Brazil is one of the worst-coronavirus hit countries with over 1.93 crore cases.